| Name | 14,15-Dehydro Budesonide |
|---|---|
| Synonyms |
(4aR,4bS,5S,6aS,6bS,9aR,10bR)-6b-Glycoloyl-5-hydroxy-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10b,11,12-decahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
2H-Naphth[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one, 4a,4b,5,6,6a,6b,9a,10b,11,12-decahydro-5-hydroxy-6b-(2-hydroxyacetyl)-4a,6a-dimethyl-8-propyl-, (4aR,4bS,5S,6aS,6bS,9aR,10bR)- Budesonide Impurity 5 |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 612.4±55.0 °C at 760 mmHg |
| Molecular Formula | C25H32O6 |
| Molecular Weight | 428.518 |
| Flash Point | 207.6±25.0 °C |
| Exact Mass | 428.219879 |
| PSA | 93.06000 |
| LogP | 3.49 |
| Vapour Pressure | 0.0±4.0 mmHg at 25°C |
| Index of Refraction | 1.607 |
| Symbol |
GHS08 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H361-H373 |
| Precautionary Statements | P260-P280 |
| Target Organs | Endocrine system |
| RIDADR | NONH for all modes of transport |